The Current Ratio as of November 2024 (TTM) for Oncolytics Biotech Inc. (ONCY) is 4.99

According to Oncolytics Biotech Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.99. This represents a change of -25.12% compared to the average of 6.67 of the last 4 quarters.

Oncolytics Biotech Inc. (ONCY) Historical Current Ratio (quarterly & annually)

How has ONCY Current Ratio performed in the past?

The mean historical Current Ratio of Oncolytics Biotech Inc. over the last ten years is 7.56. The current 4.99 Current Ratio has changed 6.50% with respect to the historical average. Over the past ten years (40 quarters), ONCY's Current Ratio was at its highest in in the March 2021 quarter at 22.15. The Current Ratio was at its lowest in in the December 2019 quarter at 1.47.

Oncolytics Biotech Inc. (ONCY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Oncolytics Biotech Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oncolytics Biotech Inc. (ONCY) Average Current Ratio

How has ONCY Current Ratio performed in the past?

The current Current Ratio of Oncolytics Biotech Inc. (ONCY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Oncolytics Biotech Inc. (ONCY) Current Ratio vs. Peers

How is ONCY’s Current Ratio compared to its peers?

Oncolytics Biotech Inc.’s Current Ratio is greater than scPharmaceuticals Inc. (4.84), less than Milestone Pharmaceuticals Inc. (19.13), greater than Seres Therapeutics, Inc. (1.38), less than aTyr Pharma, Inc. (6.07), less than DiaMedica Therapeutics Inc. (17.82), greater than Inhibikase Therapeutics, Inc. (2.32), less than X4 Pharmaceuticals, Inc. (0), less than Galera Therapeutics, Inc. (6.07), less than Terns Pharmaceuticals, Inc. (5.63), less than Day One Biopharmaceuticals, Inc. (21.02), less than HOOKIPA Pharma Inc. (14.62), greater than CureVac N.V. (3.86), greater than Reata Pharmaceuticals, Inc. (2.29), greater than Krystal Biotech, Inc. (3.21), less than Vir Biotechnology, Inc. (7.97), less than Propanc Biopharma, Inc. (8.94), greater than null (0.01),

Build a custom stock screener for Oncolytics Biotech Inc. (ONCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolytics Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncolytics Biotech Inc. (ONCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncolytics Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.